Genome British Columbia Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 2
- Investments
- 19
- Portfolio
- 12
- Exits
- 5
Genome British Columbia General Information
Description
Founded in 2000, Genome British Columbia is a not-for-profit venture capital firm based in Vancouver, Canada. The firm seeks investments in early stage companies. The firm prefers to make investments in research, entrepreneurship, life sciences, health, forestry, fisheries, aquaculture, agri-food, energy, mining and environmental sectors.
Contact Information
Website
www.genomebc.ca
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Primary Office
- Suite 400-575
- West 8th Avenue
- Vancouver, British Columbia V5Z 0C4
- Canada
+1 (604) 000-0000
Genome British Columbia Investments (19)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Stoko | 01-Jun-2021 | Early Stage VC | 00000 | Therapeutic Devices | Generating Revenue | 000 00000 |
| 0000000 | 30-Jun-2020 | 0000 00000 | Outcome Management (Healthcare) | Generating Revenue | ||
| 000000000000 00000 | 02-Jun-2020 | 00000 00000 | 00000 | Diagnostic Equipment | Bankruptcy: Liquidation | |
| 00000 0000000 | 28-May-2020 | 0000 00000 | 00.00 | Diagnostic Equipment | Generating Revenue | 0000 000000 00.0 |
| 0000000000 | 16-Apr-2020 | 00000 00000 | Business/Productivity Software | Generating Revenue | ||
| 00000 000000000000 | 30-Sep-2019 | 00000 00000 | 000 | Electronics (B2C) | Generating Revenue | |
| 000000000000 00000 | 24-Apr-2019 | 00000 00000 | 00.00 | Diagnostic Equipment | Bankruptcy: Liquidation | |
| 0000000000 0000000 | 09-Apr-2018 | 00000 00000 | 00.00 | Laboratory Services (Healthcare) | Generating Revenue | |
| Aspect Biosystems | 15-Mar-2018 | Early Stage VC | 00000 | Biotechnology | Generating Revenue | |
| CuePath Innovation | 10-Nov-2017 | Seed Round | 00.00 | Other Devices and Supplies | Generating Revenue |
Genome British Columbia Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| LightIntegra Technology (Diagnostic Equipment) | 01-Nov-2021 | Bankruptcy: Liquidation | |
| 0000000 | 14-Oct-2021 | 000000000000000000 | 00.00 |
| 000000000 00000000 | 01-Jun-2021 | 000000000000000000 | |
| Cyon Therapuetics | 01-May-2019 | Out of Business | |
| Anandia | 14-Aug-2018 | Merger/Acquisition | 000.00 |
Genome British Columbia Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialGenome British Columbia Team (10)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Pascal Spothelfer | Chief Executive Officer & President | 0 | Vancouver, Canada | ||
| Tony Brooks Ph.D | Senior Executive, Chief Financial Officer & Vice President, Entrepreneurship & Commercialization | 0 | 0 | Vancouver, Canada | |
| Federica Palma Ph.D | Chief Scientific Officer & Vice President of Sectors | Vancouver, Canada | |||
| Pat Brady | Director, Industry Innovation Programs | 0 | 0 | Vancouver, Canada | |
| Sally Greenwood | Vice President, Communications and Societal Engagement | Vancouver, Canada |
Genome British Columbia Co-Investors (17)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Boardwalk | 1 | 0 |
|
|
|
| Phoenix Venture Partners | 0 | 0 |
|
|
|
| Small World Group | 0 | 0 |
|
|
|
| UBC Seed Fund | 0 | 0 |
|
|
|
| eFund (Angel investing) | 0 | 0 |
|
|